Silence Therapeutics launches $150 million ADS follow-on offering
Reuters2026/08/10 20:01- Silence Therapeutics launched an underwritten public offering of about USD 150 million of American depositary shares in the U.S.
- Each ADS represents three ordinary shares; underwriters hold a 30-day option to buy up to 15% more ADSs.
- Jefferies, Morgan Stanley, Cantor, William Blair named joint book-running managers.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Goldman Sachs remains bullish on the South Korean stock market: Driven by the AI memory boom, with a potential upside of up to 80%.
Goldman Sachs strategist Timothy Moe maintains his bullish target on the South Korean stock market, believing that investors are underestimating how long the benefits of artificial intelligence (AI) will last for the country's memory chip manufacturers.
Oranjebtc cancels 25 million treasury shares without capital reduction
The Last Time Treasury Yields Hit 6%, Bitcoin Didn't Exist — What Happens If They Get There Again?
Crypto prices
More
